[144] Labcorp Holdings Inc. SEC Filing

Rhea-AI Filing Summary

Labcorp Holdings Inc. (LH) filed a Form 144 reporting a proposed sale of 3,903 shares of common stock with an aggregate market value of $1,059,371.39. The filing lists 83,100,000 shares outstanding and names Fidelity Brokerage Services as the broker; the sale is slated for 08/13/2025 on the NYSE.

The filing shows the securities were acquired via an option granted on 02/12/2019, with acquisition and payment dated 08/13/2025, and payment made in cash. It also reports no securities sold in the past three months for the selling person and includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Small-scale insider sale documented; likely immaterial to Labcorp's market capitalization given the share count disclosed.

The Form 144 documents a proposed sale of 3,903 common shares valued at $1,059,371.39, executed through Fidelity on the NYSE. Against the reported 83,100,000 shares outstanding, this sale represents a very small percentage of the float. The filing also discloses the acquisition method (option granted 02/12/2019) and cash payment, which clarifies the provenance of the shares. From a trading-impact perspective, the disclosed size and the absence of other recent sales suggest limited market impact.

Corporate Governance Expert

TL;DR: Standard insider disclosure of an option-derived sale; governance note: filer affirms no undisclosed material information.

The Form 144 shows compliance with Rule 144 reporting for an option-based award exercised and sold on 08/13/2025. The submission names the broker and confirms cash payment, and it records no sales in the prior three months. The included representation that the seller lacks undisclosed material adverse information is the customary attestation on these notices. Procedurally, the filing is complete for the proposed transaction described.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3903	1059371.39	83100000	08/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/13/2025	Option Granted 02/12/2019	Issuer			3903	08/13/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Labcorp (LH) shares are being proposed for sale?

The Form 144 reports a proposed sale of 3,903 shares of Labcorp common stock.

What is the aggregate market value of the shares in the LH Form 144?

The aggregate market value reported is $1,059,371.39.

When is the proposed sale of LH shares scheduled to occur?

The approximate date of sale listed is 08/13/2025.

How were the Labcorp shares acquired according to the filing?

The securities were acquired via an option granted on 02/12/2019, with acquisition and payment dated 08/13/2025.

Through which broker and exchange will the LH sale occur?

The filing names Fidelity Brokerage Services LLC as the broker and lists the NYSE as the exchange.

Does the filing report any sales of LH securities in the past three months?

The Form 144 states Nothing to Report for securities sold during the past three months by the selling person.